英文投稿作者须知
英文投稿流程
7) Pages should be numbered sequentially I have numbered pages sequentially.
Response to Reviewer Coments
I havefine the language carefully.
2) Each bullet point provided in 'Research highlights' should not exceed a maximum of 85 characters including spaces.
Comments:
1) In its current state, the level of English throughout your manuscript does not meet the journal's desired standard. There are a number of grammatical errors and instances of badly worded/constructed sentences. Please check the manuscript and refine the language carefully.
Title page
Inductively coupled plasma orthogonal acceleration time-of-flight mass spectrometry (ICP-oa-TOF-MS) analysis of heavy metal content in Indocalamus tesselatus samples Yu-Yue Qin a, *, Zhi-Hong Zhang a, Lin Li b, Chun-Sheng Chen a, Sha Shun a, Yin-Chuan Huang c aInstitute of Chemical Engineering, Kunming University of Science and Technology, 650550, Kunming, China b College of Light Industry and Food Science, South China University of Technology, Guangzhou 510640, China c Nansha entry-exit inspection and quarantine bureau, 511455, Guangzhou, China Corresponding author. Tel.: +86 13888195681; fax: +86 871 5729591 E-mail address: rabbqy@ (Y.Y. Qin).
plant didease 等APS 杂志投稿作者须知
投稿核对表在提交您的手稿供Phytopathology™, Plant Disease, MPMI®, Plant Health Progress 和Phytobiomes 杂志发表之前，请参考以下指南。
内容：1.展示研究的意义和原创性。
2.讨论部分要与已发表的研究结果相关联，并阐明本研究的优缺点。
3.主要结论要由重复性试验的支持，明确结果的再现性。
4.在文章开始部分明确阐明本实验的目的。
5.开始部分包括本研究方向的简介和相关文献。
6.稿件在提交前要严格检查。
7.如果作者想要对稿件进行润色，可在网上搜索scientific editing” 或“manuscript editingservice”. 本工作应在投稿前进行，由作者负责。
格式普通1.行编号页8 1/2*11英寸，双倍行距（包括图表的标题）。
打字稿是12点无衬线字体。
2.每个页面上要有第一作者的姓名、页码和期刊名。
3.标题不超过150个字符和空格。
寄主、病原菌和病害、现象要准确，不要兼用通用名和学名。
4.作者姓名、单位和地址写在单独的段落里。
所有的APS杂志均请参考最新格式要求。
5.通讯作者的姓名和邮箱地址写在摘要前。
6.摘要控制在250词以内。
7.关键词在摘要后。
8.根据组织和材料分布段落。
9.致谢写在正文后。
资助细节在手稿上传中提供，不应出现在该段落。
10.参考文献根据作者姓氏按字母顺序排名，在文中以作者-年份的形式呈现。
11.重复检查参考文献的准确性和完整性。
12.稿件从未发表过或同时在其他期刊投稿。
13.公开摘要可自主选择，但是Plant Disease 和Plant Health Progress 提倡。
表格1.所有表格按出现顺序列出。
表格放在参考文献部分后面单独的页面上。
2.对所有非标准缩写进行解释。
以文本的格式提交表格，而非图片。
图1.第一个单词的第一个字母要大写，其他的都小写（专有名词除外）。
2.所有图形都使用一致的字体样式和大小。
期刊carbon投稿须知
CARBON――Guide for Authors(作者指南) 《Carbon》是Elsevier和美国碳学会（American Carbon Society）合办的一个国际学术刊物。
稿件的准备所有作者在投稿之前均被要求认真阅读“投稿检查表”（Carbon Submission Checklist）如果发现一个稿件中“投稿检查表”所列项目有问题的话，该稿件将被退回给作者，请作者修改后再重新投稿。
概述所有稿件都必须是计算机文字软件处理、双倍行距、具有足够宽的页边距和使用12 pt大小的文字（推荐使用Times New Roman）。
通讯作者需用*号标识，并在第一页以页底脚标的形式给出详细的联系方式（传真号和电子邮件地址）。
必须给出所有作者的完整通信地址和所属单位。
为了保持刊物格式的一致性，编辑将保留进行格式更改的权利。
稿件的种类Carbon接受三种类型的稿件，每一种都有其单独的格式。
编辑快报（Letters to the Editor）“编辑快报”发表简短的通讯，长度不超过5页（双行间距，含参考文献）、不得超过5个图/表，建议最多不引用10个参考文献。
一篇“编辑快报”应包括不超过100字的摘要，并且不分章节。
提供的图表大小需适合缩小到杂志中的一个单列宽度（约85毫米）。
“编辑快报”必须是：（a）一个简洁的研究报告；（b）对已在Carbon上发表的其他论文进行评述。
研究论文（Research Papers）“研究论文”可以是任意长度的论文，应包括不超过200字的摘要，并分为用数字标明的如下所述的章节。
综合评述（Review Articles）“综合评述”一般由编辑邀请撰写，我们强烈建议你在投稿“综合评述”之前先与主编联系。
“综合评述”需就一个当前十分重要的研究主题或方向给予全面、系统、反映最新进展的评述，格式与“研究论文”相同，但需要在摘要之后立即给出一个目录。
请注意：所有论文都是即期发表，“编辑快报”并无优先权。
Phytotherapy Research投稿须知
外文期刊投稿须知：Phytotherapy Research（《植物药疗法研究》；ISSN：0951-418X；e-ISSN：1099-1573）是由英国John Wiley & Sons有限公司出版发行。
投稿作者只需登陆/ptr即可进行在线投稿，影响因子：1.772Dear Prof. Chen,Welcome to Phytotherapy Research - Manuscript Central site for online submission and review.Your USER ID and PASSWORD for your account at/ptr is as follows:USER ID: cxchen6@PASSWORD: Your Password: cxchen6126Please note that your log-in information is case-sensitive.Thank you for your participation.Sincerely,Phytotherapy Research Editorial OfficeYour manuscript entitled "Effects of Chinese Herb Medicine Radix Scrophulariae on Ventricular Remodeling." has been successfully submitted online and is presently being given full consideration for publication in Phytotherapy Research.Your manuscript number is PTR-10-0162. Please mention this number in all future correspondence regarding this submission.You can view the status of your manuscript at any time by checking your Author Center after logging into /ptr . If you have difficulty using this site, please click the 'Get Help Now' link at the top right corner of the site.Thank you for submitting your manuscript to Phytotherapy Research.Sincerely,Phytotherapy Research Editorial Office。
international journal of molecular sciences投稿须知
international journal of molecular sciences投稿须知
投稿须知包括以下内容：
1. 投稿类型：确定您打算投稿的文章类型，例如原创研究论文、综述、通讯等。
2. 投稿格式：按照期刊的格式要求，准备您的文章。
包括字体、字号、行间距、页边距等要求。
3. 投稿限制：确定期刊的投稿限制，例如文章长度、图片和图表数量、参考文献格式等。
4. 作者资格：确定文章的作者资格要求，例如作者应具备哪些背景、学历或研究经验。
5. 推荐人：期刊可能要求您提供推荐人的联系信息，他们可以为您的论文提供评价和推荐。
6. 提交流程：了解期刊的投稿流程，确定是否需要在线提交或通过电子邮件发送。
7. 审稿过程：了解期刊的审稿过程，包括匿名审稿还是双盲审稿，以及审稿人的选择和评审时间。
8. 费用：某些期刊可能收取投稿费用或出版费用，请确认是否需要支付相关费用。
9. 冲突声明：提交之前，请确保您已经声明任何与本研究相关的潜在利益冲突。
10. 附加材料：根据需要，您可能需要提供一些附加材料，例如原始数据、图表或补充材料。
请注意，以上内容仅供参考，具体投稿须知可能因期刊而异。
请在投稿之前仔细阅读并遵守期刊的投稿指南。
中华医学杂志英文版投稿须知
Instructions for authorsChinese Medical Journal (CMJ) is an international, peer-reviewed general medical journal published in English semimonthly by the Chinese Medical Association and distributed worldwide. Manuscripts are welcome from any part of the world.MANUSCRIPT INFORMATIONManuscript requirementsManuscripts submitted to CMJ should meet the following criteria: the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data.Manuscript submissionAuthors are required to submit their manuscripts online at .Previous publication or duplicate submissionManuscripts are considered with the understanding that they have not been published previously and are not under consideration by another publication. Copies of possibly duplicative materials that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.Previous presentationA complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) can be considered.CATEGORIES OF ARTICLESCMJ publishes editorial, original article, review article, medical progress, brief report,viewpoint, case report, letter, and many other categories of articles. Topics of interest include all subjects that relate to the practice of medicine and research.EditorialThese are usually commissioned, however, unsolicited editorials are welcome. We are keen to consider editorials or ideas for editorials from authors outside China. Editorials should be up to 2000 words long with no more than 25 references.Original articleManuscripts on epidemiological studies, studies of social medicine, clinical trials, especially large scale randomized controlled trials are welcome. Each manuscript should clearly state an objective or hypothesis, the methods, the main results of the study and the conclusions. The length is limited to 2000–4000words (not including tables, figures, and references).More than 20 references are encouraged to be cited in this kind of articles.Meta analysisOnly results of meta analysis are reported in this kind of article. The length of the article is within 2000–4000 words (not including tables, figures, and references). Medical progressThis kind of article is mainly solicited, but we also consider unsolicited articles. The length of the article is within 2000–4000 words (not including tables, figures, and references).Review articleReview articles include systematic, critical assessments of literature and data sources pertaining to different medical topics, such as cause, diagnosis, prognosis, therapy, or prevention, etc.The length is limited to 2000–4000words (not including tables, figures, and references).Brief reportThese articles are short reports of original studies. They should not exceed 2500 words with no more than 2 tables and/or two illustrations and 15 references.Clinical experienceAuthors of these articles provide their experiences for diagnosis, treatment or prevention of diseases. The length is up to 2500 words with no more than 2 tables and/or two illustrations and 15 references.ViewpointPersonal views are welcome and the length should be 1000–3000 words (not including tables, figures, and references). Authors of this type of articles should sign their real names; no anonymous pieces are published.Case reportAuthors usually describe one to three patients or a single family. The text is limited to no more than 2500 words, and up to 15 references.Clinical solutionsThe articles are evidence-based reviews of topics relevant to practicing physicians. Articles in this series should include the following sections: case report, clinical overview, strategies, clinical difficulties, and author’s personal opinions. The text is limited to 3000 words and a small number of figures and tables. Images for diagnosisAuthors can provide here with typical images of common or uncommon medical conditions. This feature is intended to capture the sense of visual discovery and variety that physicians experience. It is not intended as a vehicle for case reports.LetterLetters to editors discussing a recent CMJ article should be received within 3 months of the article’s publication and should not exceed 500 words of text and 5 references. Letters should also be submitted online.AUTHOR INFORMATIONDesignate a corresponding author and provide a complete address,telephone and fax numbers, and E-mail address.Authorship requirementsEach author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to published article. Authorship credit should be based on(1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published.Conditions 1, 2, and 3 must all be met.1Group authorshipIf authorship is attributed to a group, all members of the group must meet the full criteria and requirements for authorship as described above. A group must designate at least one individual as corresponding author. Other group members may be listed in an Acknowledgment.Conflicts of interestAuthors should indicate relevant conflicts of interest, including specific financial interests relevant to the subject of their manuscript, in their covering letter. Authors without relevant financial interests in the manuscript should indicate no such interest.EDITORIAL REVIEW AND PUBLICATIONPeer reviewA CMJ editor reviews submitted manuscripts initially. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to expert consultants for peer review. Peer reviewer identities are kept confidential.The manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. We encourage authors to suggest the names of possible reviewers, but we reserve the right of final selection. Rejected manuscriptsRejected manuscripts and reasons for rejection can be found online. EditingAccepted manuscripts are copyedited first by native speakers and then by CMJ editors according to CMJ style and returned to the author for approval. Authors are responsible for all statements made in their work, including changes made by the editor and authorized by the corresponding author.PublicationAuthors are required to pay page fee if their manuscripts are accepted for publication. The publisher will provide the author (s) 2 copies of the journal free of charge.CopyrightThe Chinese Medical Association (CMA) is the owner of all copyrights to any articles published in the journal. Published manuscripts become the permanent property of the Chinese Medical Association and may not be published elsewhere without written permission. Chinese Medical Association keeps the right to use these manuscripts in any form, including print, video, audio, and digital.MANUSCRIPT PREPARATIONManuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals by the International Committee of Medical Journal Editors (ICMJE) ().Submit the original manuscript online; use 1 side of standard-sized page and 1.5 cm margins.For Chinese authors, submission of a Chinese version of the manuscript (or abstract) is recommended.Use only 10- or 12-point font size.On the title page include the full names and affiliations of all authors. If an author’s affiliation has changed since the work was done, list the new affiliation as well. Titles should be concise and descriptive. The name, address, telephone number, fax number, and E-mail address of the correspondence author should be addressed. Any grant support that requires acknowledgment should be mentioned on this page.Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury. All hematological and clinical chemistry measurements should be reported in the metric system in terms of the International System Units (SI).Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is directly relevant to the discussion.Do not use abbreviations in the title or abstract and limit their use in the text.A covering letter signed by all authors includes(1) information on prior or duplicate publication or submission elsewhere of any part of the study; (2) the statement that the manuscript has been read and approved by all the authors and that the criteria for authorship have been met; (3) the statement on financial or other conflict of interests; and (4) any suggestions such as referring possible unqualified reviewers due to conflict of interests, etc. The corresponding author must sign the acknowledgment statement. Authors should obtain written permission from all individuals named in an acknowledgment.JOURNAL STYLETablesTables should be simple and no duplicate information should appear in the text of the article. Tables should be numbered consecutively, and headed by a concise title. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Forfootnotes use the following symbols in this sequence: *, †, ‡, §, ||, ¶, **, ††, ‡‡.FiguresComplete sets of illustrations must be submitted with legends typed on the same page. Only clear photographs are acceptable. All lettering must be legible after reduction to column size. Magnification and staining should be indicated when pertinent. AbbreviationsUse only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.Ethical requirementFor experimental investigations of human subjects, state in the Methods section that an appropriate institutional review board approved the project. For those investigators who do not have formal ethics review committees,the principles outlined in the Declaration of Helsinki2 should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants.Patient descriptions, photographs, and pedigreesInclude a signed statement of informed consent to publish (in print and online) patient descriptions, photographs, and pedigrees from all persons (parents or legal guardians for minors) who can be identified in such written descriptions, photographs, or pedigrees. Such persons should be shown the manuscript before its submission.Permissions required to reproduce or adapt material Acknowledge all text, illustrations, and tables adapted or reproduced from other publications and submit permission from the original publishers(or other copyright owner) to republish in print, online, and licensed versions of CMJ.ReferencesNumber references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references,abbreviate titles of journals according to Medline. Note: List authors and/or editors up to 6; if more than 6, list the first 6 authors followed by et al.Examples of reference style:1. Liu XP, Long DY, Dong JZ, Liu XQ, Fang DP, Hao P, et al. Recurrent atrial tachycardia and atrial fibrillation after circumferential pulmonary vein a blation: What’s the difference? Chin Med J 2005; 118: 1773-1778.2. Xie SZ, Gu MJ, Cheng YP. Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by malignant neoplasm. Chin J Obstet Gynecol (Chin)* 1998; 33: 113-114.3. Weinstein L, Swartz MN. Pathogenic properties of invading microorganisms. In: Sodeman WA Jr., Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Philadelphia: Saunders; 1974: 457-472.4. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11 Suppl 2: s369-s378.5. Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996; 23(1 Suppl 2): 89-97.6. Ozben T, Nacitarhan S, Tuncer N. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus. Ann Clin Biochem 1995;32 (Pt 3): 303-306.7. Turan I, Wredmark T, Fellander-Tsai L. Arthroscopic ankle arthrodesis in rheumatoid arthritis. Clin Orthop 1995; (320): 110-114.8. Cumulative number of reported cases of severe acute respiratory syndrome (SARS). Geneva: World Health Organization, 2003. (Accessed April 9, 2003 at http://www.who.int/csr/sarscountry/ 2003_04_04/en/.)*: It is especially needed to note “(Chin)” for articles published in Chinese.Authors are responsible for the accuracy and completeness of their references and for correct citation of the text.REPORT OF ORIGINAL DATAAbstractInclude a structured abstract of no more than 300words for original articles, meta analysis, brief report, clinical experience (Background, Methods, Results, Conclusions) and review articles (Objective, Data sources, Study selection, Results, Conclusions); an informative abstract for medical progress, viewpoint, case report, clinical solutions and images for diagnosis.KeywordsThree to 6 words or short phrases should be provided at the top of the abstract page as keywords. Terms from the medical subject heading (MeSH) list of Medline should be used; if suitable MeSH terms are not yet available for recently introduced terms, present terms may be used.IntroductionIntroduction should be short and arresting. State the purpose of the article and summarize the rationale for the study or observation. Give only strictly pertinent references and do not include data or conclusions from the work being reported.MethodsDescribe your selection of the observational or experimental subjects (patients or laboratory animals, including controls) clearly. Identify the age, sex, and other important characteristics of the subjects.Iden tify the methods, apparatus (list the manufacturer’s name and original country in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods; provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate theirlimitations. Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.Reports of randomized clinical trials should present information on all major study elements including the protocol (study population, interventions or exposures, outcomes, and the rationale for statistical analysis), assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding). Authors are recommended to refer to the CONSORT Statement 3 for details.ResultsOverall describe the major findings of the study. Present your results in logical sequence in the text, tables and illustrations. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. DiscussionSummarize the major findings. Discuss possible problems with the methods used. Compare your results with previous work. Discuss the clinical and scientific (if any) implications of your findings and their limitations. Suggest further work. Produce a succinct conclusion.MANUSCRIPT CHECKLISTSubmit complete text of your manuscript online (including tables, figures, etc), in addition, domestic authors should submit Chinese version of the complete text or its abstract.Review the sequence: covering letter, title page, key words and abstract, text, acknowledgments, references, tables, legends for illustrations.Check all references for accuracy and completeness. Put references in proper format in numerical order, making sure each is cited in the text.Include written permission from each individual identified as a source for personal communication.Include informed consent forms for identifiable patient descriptions, photographs and pedigrees.Keep copies of everything submitted.Manuscript inquiriesTel:86-10-85158321.Fax:86-10-85158333.Email:***********. cn.REFERENCES1.International Committee of Medical Journal Editors. Uniformrequirements for manuscripts submitted to biomedical journals.(Accessed September 10, 2009 at: )2.World Medical Association. Declaration of Helsinki: Ethicalprinciples for medical research involving human subjects.(Accessed September 6, 2005 at: /e/policy/ pdf/ 17c.pdf)3.Schulz KF, Altman DG, Moher D, for the CONSORT Group.The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. (Accessed October 28, 2010 at: http://www.consort- )。
英文文章投稿须知
1Manuscript should be submitted in word format through the website /jwxtcn or by email to jwxt@. The template of manuscript can be downloaded from the website homepage. There is no firmly established length, but entire paper (including tables and figures) exceeding 20 pages is discouraged. First name(s) in full and surname(s) (in capitals) of author(s), and complete addresses with superscript numbers should be given. The corresponding author much confirm by a letter that all co-authors agree to the submission.2 The abstract is ca. 150-200 words. Authority names of taxa and citations of other papers must be omitted in the abstract. A maximum of 7 key words which not repeat the words of title should be listed. The editor may change the key words.3The contents should generally be arranged in the following order: Introduction, Materials and Methods, Results (do not include parts of discussion), Discussion, Acknowledgements, References. Authority names of species and of infraspecific levels have to be mentioned when the taxa are used for the first time. Abbreviations of authority names should follow Kirk & Ansell (1992) or Brummitt & Powell (1992). All measurements must be in metric units. Abbreviations must be defined where they first appeared, except for common abbreviations, such as nm, µm, mm, cm, mg, g, kg, µL, mL, L, Da, kDa, U (enzyme unit), s, min, h, d, etc. When one unit appears in the denominator use the solidus; examples: µg/mL, mg/L, g/L, µmol/L, mmol/L, mol/L, U/µL, U/mL, etc. Words of Latin origin, like in vivo, et al., ibid. and scientific names of genera, infraspecific levels (subgenus, section), species and infrageneric levels (subspecies, variety) should be italicized.4Figures and tables must be submitted as electronic files and inserted into the text. Number tables consecutively and give a brief informative title. Each table should be self-explanatory and supplementary to the text. All abbreviations must be explained in the legends. Figures may be combined to a maximum plate size of 16cm high by 14.5cm wide. Electronic figures must be captured at or above 600dpi resolution. Designate all figures in a consecutive manner. Hand-written signs and letters are not acceptable. The captions should be self-explanatory and independent from the text. Include scale bars in the figures and explain the dimension of the scale in the legend. Colour photo is costly and must be paid for by the author.5 All references should be cited in the text, and they are set in parentheses. Commas are not used to separate the author’s name from the date. When citing several references, these should be listed in chronological not alphabetical order. Examples: Ellis (1971), Ellis (1971, 1976), (Korf & Zhuang 1987), (Kirk et al. 2001), (Baral 1994; Webster et al. 1998; Kirk et al. 2001).The reference list should be in alphabetical order by the first author’s name. Periodical titles should not be abbreviated. When several papers published in the same year by the same author(s) are listed, they should be distinguished by adding a, b, c to the year. Submitted or unpublished manuscripts may not be quoted as references (but may be quoted in the text as “unpubl.”). Master’s theses and Ph.D. dissertations may be cited, indicate as “Unpubl. Ph.D. dissert.”, or “Unpubl. MS thesis”, provide full college, university or institutional name, city and country.Examples:Agerer R, 1983. Beitrag zur Flora cyphelloider Pilze aus der Neotropis V. Zwei neue Gattungen: Metulocyphella und Incrustocalyptella. Zeitschrift für Mykologie, 49:155-164Bird C, Thomson JW, March AH, Scotter GW, Wong PY, 1981. Lichens from the area drained by the Peel and Mackenzie rivers, Yukon and Northwest Territories, Canada. Ⅱ. Microlichens. Canadian Journal of Botany, 59:1231-1252Cummins GB, 1978. Rust fungi on legumes and composites in North America. University of Arizona Press, Tucson, Arizona. 1-424Oberwinkler F, 1993. Diversity and phylogenetic importance of tropical heterobasidiomycetes. In: Isaac S, Frankland JC, Watling R, Whalley AJS (eds.) Aspects of tropical mycology. Cambriage University Press. 121-1476 20 reprints of each paper will be furnished free of charge. Copyright on all papers including the figures is held by Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.。
英文论文写作投稿注意事项
【写作前准备】1、自己的实验结果是否够发一篇SCI文章？2、适合发表在什么杂志？是选择专业期刊？还是综合期刊？3、为什么类型的投稿（Types of submission）？比如Articles（论著）；Reviews（综述）；Reports （报告）；Letter to editor（来信）等。
4、该杂志的影响因子（Impact factor）是多少，每年发表多少文章？是否有过本土中国人在上面发表？（便于评价自己的文章被接收的可能性）。
6、有没有下载该杂志最新的投稿须知（Instructions for authors）？7、是否弄清楚了投稿须知各个条目的意思？8、是否接收网上投稿(Submission on line)（一般有网上投稿的杂志更为方便）？9、是否收版面费(Page charges)？如果论文被接收，自己的经济能力能否支付该杂志的发表全部费用。
10、手头有多少相关内容的文献？（越多越好，这样写作的时候能借鉴他们的思路和语句，对分析讨论的开展也很有好处）【写作环节】1、不要用中国式的思维去写英文句子。
2、套用老外的写作思路（比如前言第1段写对疾病的认识及重要性，第2段对基本背景知识的介绍，第3段如何引出研究问题。
讨论部分往往每一段第一句为该段的中心句。
）3、格式一定要严格按照所投杂志的要求来排版（可以参考投稿须知的要求和该杂志最近发表的文章，要做到一模一样，这样编辑认为你是认真对待的）。
4、避免使用首次发现，该研究特别有意义的语句（老外喜欢你陈述事实，是不是首次发现由别人说了算，有没有意义需要时间来检验）。
5、首页有什么特殊要求？比如是否写清了通讯作者（Corresponding author）和页眉标题（Running title），Running title是否符合字符数要求，一般50个字符以下。
首页是否要求标明全文字符数（The number of characters must be listed on the title page）。
- 1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。
ONETABLE OF CONTENTSSelect an item in the table of contents to go to that topic in the document.LOGGING ON AND OFF THE AUTHOR CENTER (2)LOGGING ON (2)LOGGING OFF (3)FORGOT YOUR PASSWORD? (3)HELP DOCUMENTATION (4)THE WELCOME PAGE (4)INSTRUCTIONS AND FORMS (4)THE AUTHOR DASHBOARD (5)THE MANUSCRIPT SUBMISSION PROCESS (5)IMPORTANT NOTES (6)STEP 1 – TYPE, TITLE, & ABSTRACT (7)SUBMITTING AGENT QUESTION (8)STEP 2 – ATTRIBUTES & KEYWORDS (8)STEP 3 – AUTHORS & INSTITUTIONS (9)STEP 4 – REVIEWERS & EDITORS (10)STEP 5 – DETAILS & COMMENTS (12)STEP 6 – FILE UPLOAD (13)ZIP FILES AND LATEX DOCUMENTS (14)STEP 7 – REVIEW & SUBMIT (15)TIPS FOR AUTHORS SUBMITTING A REVISION (16)LOGGING ON AND OFF THE AUTHOR CENTERLOGGING ONEach journal’s ScholarOne Manuscripts site has a unique Web address (URL). Typically, you are given the address in an email sent by the journal. If the address is hyperlinked, select the link within the email, or copy and paste into the browser. The journal’s Log In page is displayed.Access to the journal site may be provided in two ways:1.The journal may create your account and email to you instructions on how to log in and set your UserID and password.2.Some journals allow their users to create their own accounts. If yours does, there will be a CreateAccount link in the top right corner of the page, or you can use the New User? Register here just to the right of the Log In. Follow the 3-step process for creating your account.•Journal-required fields are denoted by the required symbolNOTE: Your User ID or Password cannot contain any spaces and your password must be at least 8 characters in length (the 8 characters must contain two or more numbers).To keep your account information current, use the Edit Account link in the upper right corner after you have logged into the site.LOGGING OFFYou can log out of ScholarOne Manuscripts at any time by selecting Log Out at the top right corner of the page. You will be returned to the Log In page.FORGOT YOUR PASSWORD?If you know you have an account but have forgotten your password, use the Password Help field and select . The system will send you an e-mail with your account information or link to reset your password. Please be sure to check your spam folder as our email is sometimes treated as spam.HELP DOCUMENTATIONOnline training documentation is available through the Get Help Now link at the top right of all journal site pages and through the Resources section on the Log In and Welcome pages.THE WELCOME PAGEWhen you log in, you are taken to the Welcome page. Here you see links to all of the role centers you have permissions for in this journal. Typically, authors are given both Author and Reviewer permissions, although this varies by journal.To access your author dashboard page, select the link.INSTRUCTIONS AND FORMSAccess journal-specific Instructions and Forms in the Resources section of the welcome screen, or when you enter your Author center.THE AUTHOR DASHBOARDThe Author Dashboard is where you begin the manuscript submission process. You can track the status and view the details of all your manuscripts in the journal’s ScholarOne Manuscripts site. Select the appropriate queue in the My Manuscripts section. The results will display directly below the dashboard.THE MANUSCRIPT SUBMISSION PROCESSTo begin the submission process, select the here link in your dashboard’s Author Resources section:IMPORTANT NOTES•Each journal can configure ScholarOne Manuscripts to ask for different pieces of information and different required fields from the examples shown in this guide•Journal-required fields are denoted by the required symbol•Journals may vary the requirements based on manuscript type•Always follow journal instructions carefully when submitting manuscriptsSTEP 1 – TYPE, TITLE, & ABSTRACTSUBMITTING AGENT QUESTIONYour site may also have a question regarding if you are a submitting agent or one of the actual authors of the paper.STEP 2 – ATTRIBUTES & KEYWORDSAttributes or keywords are often required for manuscript submission. Some journals have a list of keywords for you to choose from, others allow authors to enter their own keywords, and some sites allow for both options.STEP 3 – AUTHORS & INSTITUTIONSEnter or confirm your name and institution information and add any co-authors and their information. The journal may have limits set on the number of co-authors you can enter and the number of institutions per authorSTEP 4 – REVIEWERS & EDITORSSome journals allow you or require you to add Preferred and/or Non-Preferred Reviewers and/or Editors for your manuscript.Actions Notes1.Add a Reviewer: Enter information in thefields.STEP 5 – DETAILS & COMMENTSThis page is journal-specific and may include an area for a cover letter, as well as any other required submission information.STEP 6 – FILE UPLOADIn this step you will upload all of your manuscript files.ZIP FILES AND LATEX DOCUMENTSIf configured for your journal, your zipped files can be uploaded in the Upload zipped files section. The contents of the file will be unpacked and processed automatically. A selected file designation will be added to each extracted file in the My Files list.For TeX/LaTeX submissions, the package contents will be unpacked, parsed, and processed to determine the identity of the LaTeX content files. The files can then be assigned to their file designations automatically, based on the journal’s configuration, and uploaded to the manuscript. Be sure that the very first file presented in your file listing is the main LaTeX file.STEP 7 – REVIEW & SUBMITThis is a final review step before submitting your manuscript. All sections must display the green checkmark before you can submit to complete the submission process.TIPS FOR AUTHORS SUBMITTING A REVISIONTo start your revision, you will need to log back into your Author Center and find the Manuscripts withDecisions queue. Selecting this queue will bring up the paper at the bottom of the screen with an Action of create a revision . Click on the action to submit your revised paper. Depending on your journal the link may say create a resubmission .NOTE: If you do not see the link, your time has expired to create a revision and you will need to contact the journal office for an extension. Once the extension is granted, the link will reappear.If you have already started a revision, this is noted by the “a revision has been started ” action under “Manuscripts with Decisions”. The revision is now located in the “Revised Manuscripts in Draft ” queue. To access the revision, click on that link under the “My Manuscripts ” heading in the author center. You should then see the correct revision appear at the bottom of the page. Clicking the “Continue Submission ” button will allow you to work on and submit your revised manuscript.SCHOLARONE®ScholarOne, a Thomson Reuters Business, provides comprehensive workflow management systems for scholarlyjournals, books, and conferences. Its web-based applications enable publishers to manage the submission, peerreview, production, and publication processes more efficiently, increasing their profile among authors, decreasing time-to-market for critical scientific data, and lowering infrastructure costs. ScholarOne offers workflow solutions for thesubmission and review of manuscripts, abstracts, proceedings, books, grants & awards, and production. Supportingover 365 societies and publishers, over 3,400 books and journals, and 13 million users, ScholarOne is the industryleader.FIND OUT MORE ABOUT SCHOLARONETo learn more, visit or contact the office nearest you.Science Head OfficesAmericasScholarOne +1 434 964 4000Philadelphia +1 800 336 4474+1 215 386 0100Europe, Middle East, and AfricaLondon +44 20 7433 4000Asia PacificSingapore +65 6775 5088Tokyo +81 3 5218 6500For a complete office list visit:/contactCopyright ©2013 Thomson Reuters All rights reserved。